308 related articles for article (PubMed ID: 22075614)
21. Intravesical botulinum toxin a injections do not benefit patients with ulcer type interstitial cystitis.
Lee CL; Kuo HC
Pain Physician; 2013; 16(2):109-16. PubMed ID: 23511677
[TBL] [Abstract][Full Text] [Related]
22. Heparin and alkalinized lidocaine versus alkalinized lidocaine for treatment of interstitial cystitis symptoms.
Parsons CL; Koziol JA; Proctor JG; Zupkas P; Argade S
Can J Urol; 2015 Apr; 22(2):7739-44. PubMed ID: 25891339
[TBL] [Abstract][Full Text] [Related]
23. The effect of intravesical hyaluronic acid therapy on urodynamic and clinical outcomes among women with interstitial cystitis/bladder pain syndrome.
Peng YC; Yueh-Hsia Chiu S; Feng M; Liang CC
Taiwan J Obstet Gynecol; 2020 Nov; 59(6):922-926. PubMed ID: 33218413
[TBL] [Abstract][Full Text] [Related]
24. Advances in intravesical therapy for bladder pain syndrome (BPS)/interstitial cystitis (IC).
Meng E; Hsu YC; Chuang YC
Low Urin Tract Symptoms; 2018 Jan; 10(1):3-11. PubMed ID: 29341502
[TBL] [Abstract][Full Text] [Related]
25. Urinary and psychological outcomes in women with interstitial cystitis/bladder pain syndrome following hyaluronic acid treatment.
Liang CC; Lin YH; Hsieh WC; Huang L
Taiwan J Obstet Gynecol; 2018 Jun; 57(3):360-363. PubMed ID: 29880165
[TBL] [Abstract][Full Text] [Related]
26. [The study of diagnosis and treatment of interstitial cystitis].
Sun ZQ; Qian WQ; Xie DS; Song JD
Zhonghua Wai Ke Za Zhi; 2005 May; 43(10):659-61. PubMed ID: 16008941
[TBL] [Abstract][Full Text] [Related]
27. A rational combination of intravesical and systemic agents for the treatment of interstitial cystitis.
Taneja R; Jawade KK
Scand J Urol Nephrol; 2007; 41(6):511-5. PubMed ID: 17853025
[TBL] [Abstract][Full Text] [Related]
28. Treatment of interstitial cystitis.
Chancellor MB; Yoshimura N
Urology; 2004 Mar; 63(3 Suppl 1):85-92. PubMed ID: 15013658
[TBL] [Abstract][Full Text] [Related]
29. Continuous intravesical lidocaine treatment for interstitial cystitis/bladder pain syndrome: safety and efficacy of a new drug delivery device.
Nickel JC; Jain P; Shore N; Anderson J; Giesing D; Lee H; Kim G; Daniel K; White S; Larrivee-Elkins C; Lekstrom-Himes J; Cima M
Sci Transl Med; 2012 Jul; 4(143):143ra100. PubMed ID: 22814850
[TBL] [Abstract][Full Text] [Related]
30. Assessment of symptomatic response to intravesical alkalinized lidocaine, bupivacaine, heparin and steroids in patients with bladder pain syndrome.
Mahant R; Solanki FS; Tiwari C; Lokhande A; Sharma DB; Sharma D
Trop Doct; 2024 Jul; 54(3):255-257. PubMed ID: 38497135
[TBL] [Abstract][Full Text] [Related]
31. [Intravesical instillation of resiniferatoxin for the patients with interstitial cystitis].
Takahashi S; Yanase M; Inoue R; Ichihara K; Masumori N; Tsukamoto T; Igawa Y; Nishizawa O
Hinyokika Kiyo; 2006 Dec; 52(12):911-3. PubMed ID: 17252971
[TBL] [Abstract][Full Text] [Related]
32. Interstitial cystitis: urgency and frequency syndrome.
Metts JF
Am Fam Physician; 2001 Oct; 64(7):1199-206. PubMed ID: 11601802
[TBL] [Abstract][Full Text] [Related]
33. Recent developments of intravesical therapy of painful bladder syndrome/interstitial cystitis: a review.
Toft BR; Nordling J
Curr Opin Urol; 2006 Jul; 16(4):268-72. PubMed ID: 16770126
[TBL] [Abstract][Full Text] [Related]
34. Sexual function is a determinant of poor quality of life for women with treatment refractory interstitial cystitis.
Nickel JC; Tripp D; Teal V; Propert KJ; Burks D; Foster HE; Hanno P; Mayer R; Payne CK; Peters KM; Kusek JW; Nyberg LM;
J Urol; 2007 May; 177(5):1832-6. PubMed ID: 17437831
[TBL] [Abstract][Full Text] [Related]
35. Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis/bladder pain syndrome.
Nickel JC; Hanno P; Kumar K; Thomas H
Urology; 2012 Jun; 79(6):1220-4. PubMed ID: 22516357
[TBL] [Abstract][Full Text] [Related]
36. Open Label, Pilot Evaluation of the Safety and Efficacy of Intravesical Sustained Release System of Lidocaine and Oxybutynin (TRG-100) for Patients With Interstitial Cystitis/Bladder Pain Syndrome, Overactive Bladder and Patients With Retained Ureteral Stents Following Endourological Interventions.
Raisin G; Dothan D; Perez D; Ala-Adin N; Kafka I; Shenfeld O; Hatumi S; Malchi N; Gordon A; Touitou D; Moldwin R; Nassar T; Chertin B
Urology; 2023 Aug; 178():42-47. PubMed ID: 37268171
[TBL] [Abstract][Full Text] [Related]
37. A real-life multicentre clinical practice study to evaluate the efficacy and safety of intravesical chondroitin sulphate for the treatment of interstitial cystitis.
Nickel JC; Egerdie B; Downey J; Singh R; Skehan A; Carr L; Irvine-Bird K
BJU Int; 2009 Jan; 103(1):56-60. PubMed ID: 18778342
[TBL] [Abstract][Full Text] [Related]
38. Multiple intravesical instillations of low-dose resiniferatoxin in the treatment of refractory interstitial cystitis.
Peng CH; Kuo HC
Urol Int; 2007; 78(1):78-81. PubMed ID: 17192738
[TBL] [Abstract][Full Text] [Related]
39. [Anesthetic management of patients with interstitial cystitis during intravesical resiniferatoxin therapy].
Komura M; Kuroiwa M; Numazawa K; Yamada T; Hoka S
Masui; 2005 Feb; 54(2):149-52. PubMed ID: 15747509
[TBL] [Abstract][Full Text] [Related]
40. Do cystometric findings predict the results of intravesical hyaluronic acid in women with interstitial cystitis?
Daha LK; Riedl CR; Lazar D; Hohlbrugger G; Pflüger H
Eur Urol; 2005 Mar; 47(3):393-7; discussion 397. PubMed ID: 15716206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
